GlassScriptPhysician profile
David M Shain
NPI 1447719505
$10,328.39
in general payments reported to CMS, 2019-2025
19 companies · $127 in 2025
The $127 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $116 · 2020: $305 · 2021: $2,986 · 2022: $5,895 · 2023: $508 · 2024: $391 · 2025: $127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,026.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,025.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pinnacle, INC | $3,629.40 | 2021-2022 | |
| Gemini Mountain Medical, LLC | $2,833.56 | 2022-2024 | |
| Arthrex, INC. | $1,478.08 | 2022 | |
| Smith+Nephew, INC. | $535.67 | 2020-2023 | Evos, Evos Mini |
| Medical Device Business Services, INC. | $342.65 | 2021 | |
| Stryker Corporation | $328.98 | 2019-2022 | |
| Paragon 28, INC. | $291.55 | 2021-2024 | Precision Mis Bunion, Monkey Rings |
| Paratek Pharmaceuticals, INC. | $137.00 | 2023 | Nuzyra |
| Angiodynamics, INC. | $127.25 | 2025 | Auryon Laser System 100-120 Vac |
| Pacira Pharmaceuticals Incorporated | $121.46 | 2024 | Exparel |
| Organogenesis INC. | $118.03 | 2023 | Puraply |
| Amniox Medical, INC. | $92.30 | 2020 | |
| Misonix INC | $77.57 | 2020 | |
| Becton, Dickinson and Company | $58.33 | 2019 | |
| Depuy Synthes Sales INC. | $51.99 | 2019-2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $40.99 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Amgen INC. | $28.34 | 2024 | Krystexxa |
| Convatec INC. | $20.39 | 2024 | |
| Innovation Technologies INC | $14.85 | 2023 | Irrisept |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Shain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.